Cargando…
HMGA2 Polymorphisms and Hepatoblastoma Susceptibility: A Five-Center Case-Control Study
BACKGROUND: Hepatoblastoma is a rare disease. Its etiology remains obscure. No epidemiological reports have assessed the relationship of High Mobility Group A2 (HMGA2) single nucleotide polymorphisms (SNPs) with hepatoblastoma risk. This case-control study leads as a pioneer to explore whether HMGA2...
Autores principales: | Li, Li, Zhuo, Zhenjian, Yang, Zhen, Zhu, Jinhong, He, Xiaoli, Yang, Zhonghua, Zhang, Jiao, Xin, Yijuan, He, Jing, Zhang, Tiesong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023882/ https://www.ncbi.nlm.nih.gov/pubmed/32104047 http://dx.doi.org/10.2147/PGPM.S241100 |
Ejemplares similares
-
YTHDF1 rs6090311 A>G polymorphism reduces Hepatoblastoma risk: Evidence from a seven-center case-control study
por: Luo, Zhendong, et al.
Publicado: (2020) -
LIN28B gene polymorphisms modify hepatoblastoma susceptibility in Chinese children
por: Yang, Zhonghua, et al.
Publicado: (2020) -
WTAP Gene Variants Confer Hepatoblastoma Susceptibility: A Seven-Center Case-Control Study
por: Zhuo, Zhen-Jian, et al.
Publicado: (2020) -
LIN28A polymorphisms and hepatoblastoma susceptibility in Chinese children
por: Yang, Zhonghua, et al.
Publicado: (2021) -
METTL1 gene polymorphisms synergistically confer hepatoblastoma susceptibility
por: Ge, Lili, et al.
Publicado: (2022)